Has Tyler Berzin, MD received payments from drug or device companies?

Yes. Drug and device makers reported $215,450 in general payments to Tyler Berzin, MD across 169 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tyler Berzin, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tyler Berzin, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tyler Berzin, MD

Gastroenterology · Boston, MANPI 1376597641

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $184,632 of the $215,450 with a category attached, or 85.7%. 17 manufacturers reported payments, led by Medtronic at 38.5% of the total. Among gastroenterology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$215,450in general payments, 2019–2025

Across 169 payments — averaging $1274.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$83K
Boston Scientific$66K
Sanofi US Services Inc.$14K
Conmed Corporation$13K
Covidien LP$10K
Amgen$8K
plus $22K from 11 others

$3,460in research payments, 2019–2025

Across 12 payments — averaging $288.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Sanofi US Services Inc.$3K
Novo Nordisk AS$835

What the payments were for

Consulting fees$184,63286%
Speaking & faculty fees$15,3007%
Travel & lodging$10,9815%
Food & beverage$4,5362%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	67	$83,028
Boston Scientific	65	$66,127
Sanofi US Services Inc.	7	$14,050
Conmed Corporation	5	$13,193
Covidien LP	4	$9,627
Amgen	4	$7,625
Beckman Coulter, Inc.	1	$6,000
Micro-tech Endoscopy USA, Inc.	2	$4,976
Eli Lilly	1	$3,600
Fujifilm New Development USA, Inc.	3	$2,700
Olympus Medical Systems Corporation	1	$2,065
Odin Medical Limited	1	$1,340
Gyrus ACMI, Inc.	1	$500
Vascular Technology, Inc.	1	$350
Cook Medical LLC	1	$107
AbbVie	1	$93
Olympus America Inc.	4	$69

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GI Genius$32,923
GENERAL HEMOSTASIS$17,800
EXALT Model D$12,675
GENERAL - THERAPIES$12,625
BEAMER SYSTEM$10,783
DXI 9000 Access Immunoassay Analyzer$6,000
EndoScreener$4,900
SHOULDER MANUAL INSTRUMENTS$2,309
GASTROINTESTINAL VIDEOSCOPE$2,065
PillCam$1,900
AXIOS$1,464
DUPIXENT$1,000
GENERAL ENDOCHOICE$240
CAPTIVATOR II$148
GENERAL - BILIARY DEVICES$143
SPYGLASS$137
ORISE$126
HYDRATOME RX 44$108
EchoTip$107
CONMED GENERATORS$102

How this compares

$215,450 in reported general payments places this provider in the 95th percentile of 579 gastroenterology providers in Massachusetts.

See all gastroenterology providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$214,944

Medicare patients

653

Services billed

1,192

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates	194	$14,212
MovantikNaloxegol Oxalate	12	$4,813
Lansoprazole	15	$4,393
Sucralfate	13	$4,238
ClenpiqSod Picosulf/Mag Ox/Citric Ac	17	$3,468
Omeprazole	90	$2,522
SutabSod Sulf/Pot Chloride/Mag Sulf	11	$1,979
Pantoprazole Sodium	22	$498
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg	15	$296
Lidocaine Hcl ViscousLidocaine Hcl	14	$209
Ciprofloxacin Hcl	13	$37

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Boston

Hiroyuki AiharaBoston$728K
Jessica AllegrettiBoston$696K
John LeungBoston$682K
Ramnik XavierBoston$567K
Adam CheifetzBoston$512K
Carlo TraversoBoston$447K
Marvin RyouBoston$162K
Nneka UfereBoston$153K
Christopher ThompsonBoston$127K
Scott SnapperBoston$126K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →